Work

Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e13007

Authors: J. P. Kirkpatrick, J. J. Vredenburgh, A. Desjardins, S. Gururangan, K. B. Peters, S. T. Boulton, A. H. Friedman, H. S. Friedman, D. A. Reardon

Institution: Duke Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597352001

Cites:

Cited by: 5

Related to: 10